Health Care

Update On Stocks: Biogen Inc. (NASDAQ:BIIB), Sarepta Therapeutics, Inc. (NASDAQ:SRPT)

0 94

Biogen Inc. (NASDAQ:BIIB) went higher by +7.64% to close at $ 282.45. The company exchanged total volume of 5.55 million shares throughout course of last trade however it holds an average trading capacity of 1.85 million shares. Shares of company began trading at $279.76 climbed to high of $282.54 touched the low of $274.23.

The company is trading above its 50-day moving averages of 250.14 and up from 200-day moving averages of 262.95. The firm has price to book ratio of 5.57 and its price to sale ratio was 5.26.

Biogen Inc.’s (BIIB) has price-to-cash ratio of 17.24 and price to sale ratio of 5.65. The company net profit margin is 33.80% and gross profit margin is 88.70%. A look on the firm performance, its monthly performance is 21.22% and a quarterly performance of 1.02%. The stock price is moving up from its 20 days moving average with 14.74% and isolated positively from 50 days moving average with 10.22%.

Biogen Inc. (BIIB) recently stated q2 2016 financial results, including:

 

Total revenues of $2.9 billion, a 12% raise versus the same period in the previousyear.

Growth was driven by raises in worldwide revenues from the Company’s multiple sclerosis (MS) and hemophilia businesses.

Foreign exchange negatively impacted total revenues by about $44 million compared to the q2 of 2015, driven by changes in hedge results.

Growth was driven by raises in worldwide revenues from the Company’s multiple sclerosis (MS) and hemophilia businesses.

Foreign exchange negatively impacted total revenues by about $44 million compared to the q2 of 2015, driven by changes in hedge results.

GAAP net income attributable to Biogen Inc. of $1.0 billion, a 13% raise versus the same quarter in the previous year.

Brokerage Recommendations:

According to ZACKS data, different Brokerage Firms rated the stock about their BUY, SELL or HOLD recommendations. 1 Month Ago,  shares have been suggested as “BUY” from “6” brokerage firms and recommended as “Strong Buy” by “2” brokerage firms. 0” brokerage firms have issued “Sell” rating for the company and “Strong Sell” rating was issued by “1.79” brokerage firms. “0” brokerage firms have rated the company as a “Hold”. The Corporation has average brokerage recommendation (ABR) of 0 based on consensus of the brokerage firms issuing ratings.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) surged +0.85% and closed the trade at $ 22.65. The company recorded a trading capacity of 2.37 million shares below its three months average daily volume of 7.21 million shares. During the last trade, shares reached to high price of $23.41 and touched the low price of $22.33. The stock’s 50-day moving average is noted at $19.40 and its 200-day moving average is stands at $18.32.

Additionally, the company has EPS of -5.03. The company has market capitalization of $1.04B.

The average true range of Sarepta Therapeutics, Inc.’s (SRPT) is recorded at 1.31 and the relative strength index of the stock stands 62.45. The stock price is going above to its 52 week low with 183.12% and lagging behind from its 52 week high with -46.03%. Analyst recommendation for this stock stands at 2.70. A look on the firm performance, its monthly performance is 32.84% and a quarterly performance of 14.92%. The stock price is trading downbeat from its 200 days moving average with -0.31% and up from 50 days moving average with 18.15%.

Brokerage Recommendations:

According to ZACKS data, different Brokerage Firms rated the stock about their BUY, SELL or HOLD recommendations. 1 Month Ago,  shares have been suggested as “BUY” from “5” brokerage firms and recommended as “Strong Buy” by “1” brokerage firms. 3” brokerage firms have issued “Sell” rating for the company and “Strong Sell” rating was issued by “3” brokerage firms. “1” brokerage firms have rated the company as a “Hold”. The Corporation has average brokerage recommendation (ABR) of 0 based on consensus of the brokerage firms issuing ratings.

 

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.

Newsletter